{
    "code": "02025106",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=02025106",
    "time": "2022-07-22 09:39:20",
    "許可證字號": "衛署藥輸字第025106號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/10\/29",
    "發證日期": "98\/10\/29",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA00202510607",
    "中文品名": "威克倦持續性藥效錠150毫克",
    "英文品名": "Wellbutrin XL 150 mg Tablet “Canada”",
    "適應症": "治療憂鬱症",
    "劑型": "121持續性藥效錠",
    "包裝": "2-1000錠塑膠瓶裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "BUPROPION HYDROCHLORIDE",
    "限制項目": "02輸　入 25監視中學名藥",
    "申請商名稱": "1410506200  荷商葛蘭素史克藥廠股份有限公司台灣分公司",
    "申請商地址": "台北市中正區忠孝西路一段66號23-24樓",
    "主製造廠": [
        {
            "製造廠名稱": "FCA0068000  Bausch Health Companies Inc.",
            "製造廠廠址": "100 LIFESCIENCES PARKWAY STEINBACH, MANITOBA, CANADA R5G 1Z7",
            "製造廠公司地址": "",
            "製造廠國別": "CANADA",
            "製程": ""
        }
    ],
    "次製造廠": [
        {
            "製造廠名稱": "6132061151  裕利股份有限公司",
            "製造廠廠址": "桃園市大園區和平里1鄰開和路91號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": "二級包裝廠(委託貼標及置入仿單)"
        },
        {
            "製造廠名稱": "FES0122000  GLAXO WELLCOME, S.A.",
            "製造廠廠址": "AVENIDA EXTREMADURA 3, ARANDA de DUERO, BURGOS 09400, SPAIN",
            "製造廠公司地址": "",
            "製造廠國別": "SPAIN",
            "製程": "分包裝廠"
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "9250001110",
            "成分名稱": "BUPROPION HYDROCHLORIDE",
            "含量描述": "",
            "含量": "150.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "0.8cm*0.8cm 錠劑",
        "特殊劑型": "",
        "顏色": "乳白色",
        "特殊氣味": "",
        "刻痕": "無",
        "形狀": "圓凸形",
        "標記一": "GS 5FV",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "020251060004-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025106&Seq=004&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Wellbutrin XL 150mg and 300mg_仿單核定本-111-05-04.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025106&Seq=023&Type=9"
        },
        {
            "title": "Wellbutrin XL 150mg 標籤-111-05-06(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025106&Seq=016&Type=8"
        },
        {
            "title": "Wellbutrin XL 150mg 外盒-111-05-06(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025106&Seq=015&Type=8"
        },
        {
            "title": "自行變更Label_Wellbutrin XL150mg_packaging site change-111-04-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025106&Seq=014&Type=8"
        },
        {
            "title": "自行變更Carton_WELLBUTRIN XL 150MG_packaging site change-111-04-21(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025106&Seq=013&Type=8"
        },
        {
            "title": "02-025106_標籤-108-07-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025106&Seq=012&Type=8"
        },
        {
            "title": "02-025106_外盒-108-07-09.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=02025106&Seq=011&Type=8"
        }
    ]
}